个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Short-term outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a single-center retrospective study

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Pan Hanbo[1] * ; Zou Ningyuan[1] * ; Tian Yu[1] * ; Zhu Hongda[1] ; Zhang Jiaqi[1] ; Jin Weiqiu[1] ; Gu Zenan[1] ; Ning Junwei[1,2] ; Li Ziming[3] ; Kong Weicheng[1,4] ; Jiang Long[1] ; Huang Jia[1] ; Luo Qingquan[1] ;
机构： [1]Department of Thoracic Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [2]Department of Thoracic Surgery, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [3]Department of Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [4]Department of Thoracic Surgery, Putuo District People's Hospital, Zhejiang, China.
出处：
DOI： 10.3389/fimmu.2023.1228451
ISSN：

关键词： non-small cell lung cancer robot-assisted thoracoscopic surgery video-assisted thoracoscopic surgery neoadjuvant immunochemotherapy perioperative outcomes recurrence-free survival

摘要：
Neoadjuvant immunochemotherapy has been increasingly applied to treat non-small cell lung cancer (NSCLC). However, the comparison between robotic-assisted thoracoscopic surgery (RATS) and video-assisted thoracoscopic surgery (VATS) in the feasibility and oncological efficacy following neoadjuvant immunochemotherapy is scarce. This study aims to assess the superiorities of RATS over (VATS) concerning short-term outcomes in treating NSCLC patients with neoadjuvant immunochemotherapy.NSCLC patients receiving RATS or VATS lobectomy following neoadjuvant immunochemotherapy at Shanghai Chest Hospital from 2019 to 2022 were retrospectively identified. Baseline clinical characteristics, perioperative outcomes, and survival profiles were analyzed.Forty-six NSCLC patients with neoadjuvant immunochemotherapy were included and divided into the RATS (n=15) and VATS (n=31) groups. The baseline clinical characteristics and induction-related adverse events were comparable between the two groups (all p>0.050). The 30-day mortality in the RATS and VATS groups were 0% and 3.23%, respectively (p=1.000). Patients undergoing RATS were associated with reduced surgical-related intensive unit care (ICU) stay than those receiving VATS (0.0 [0.0-0.0] vs. 0.0 [0.0-1.0] days, p=0.026). Moreover, RATS assessed more N1 LNs (6.27 ± 1.94 vs 4.90 ± 1.92, p=0.042) and LN stations (3.07 ± 1.03 vs 2.52 ± 0.57, p=0.038) compared with VATS. By comparison, no difference was found in surgical outcomes, pathological results, and postoperative complications between the RATS and VATS groups (all p>0.050). Finally, RATS and VATS achieved comparable one-year recurrence-free survival (82.96% vs. 85.23%, p=0.821) and the timing of central nervous system, LN, and bone recurrences (all p>0.050).RATS is safe and feasible for NSCLC patients with neoadjuvant immunochemotherapy, reducing surgical-related ICU stay, assessing increased N1 LNs and stations, and achieving similar survival profiles to VATS.Copyright © 2023 Pan, Zou, Tian, Zhu, Zhang, Jin, Gu, Ning, Li, Kong, Jiang, Huang and Luo.

基金：
This work was supported by the National Nature Science Foundation (Grant No. 81772482), the Joint Clinical Research Centre of Institute of Medical Robotics@SJTU-Shanghai Chest Hospital (IMR-XKH202104), and the Shanghai Hospital Development Center (Grant No. SHDC12016113).
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 2 区 医学
小类 | 2 区 免疫学
最新[2023]版：
大类 | 2 区 医学
小类 | 2 区 免疫学
JCR分区：
出版当年[2021]版：
Q1 IMMUNOLOGY
最新[2023]版：
Q1 IMMUNOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Department of Thoracic Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Pan Hanbo,Zou Ningyuan,Tian Yu,et al.Short-term outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a single-center retrospective study[J].FRONTIERS IN IMMUNOLOGY.2023,14:doi:10.3389/fimmu.2023.1228451.
APA：
Pan Hanbo,Zou Ningyuan,Tian Yu,Zhu Hongda,Zhang Jiaqi...&Luo Qingquan.(2023).Short-term outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a single-center retrospective study.FRONTIERS IN IMMUNOLOGY,14,
MLA：
Pan Hanbo,et al."Short-term outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a single-center retrospective study".FRONTIERS IN IMMUNOLOGY 14.(2023)

相关文献

[1]Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Populations: A Multi-Center Retrospective Cohort Study [2]Short- and long-term outcomes of robotic-assisted versus video-assisted thoracoscopic lobectomy in non-small cell lung cancer patients aged 35 years or younger: a real-world study with propensity score-matched analysis [3]Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical Stage IA Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study [4]Early outcomes of minimally invasive surgery versus thoracotomy for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a multi-center real-world study [5]SNPs in LncRNA genes are associated with non-small cell lung cancer in a Chinese population [6]胸腔镜手术治疗创伤性血胸 [7]Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer [8]Genetic Polymorphisms in the Vitamin D Pathway and Non-small Cell Lung Cancer Survival [9]EXPRESSION OF IL-17A, E, AND F AND THEIR RECEPTORS IN NON-SMALL-CELL LUNG CANCER [10]Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer

资源点击量：21169 今日访问量：0 总访问量：1219 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持：重庆聚合科技有限公司 地址：北京市东城区东交民巷1号(100730)